About LexiAI

LexiAI is a regulatory intelligence operating system built for the life sciences industry. It empowers pharmaceutical and medtech companies to navigate the complex landscape of drug and device naming with confidence and speed. Our platform combines artificial intelligence with deep regulatory expertise to screen brand names against FDA, EMA, and global health authority databases, ensuring compliance before submission.

The platform serves regulatory affairs professionals, brand and marketing teams, clinical trial managers, and legal departments who need to ensure that proposed product names meet stringent regulatory requirements. Whether you are launching a new drug, developing a medical device, or expanding into international markets, LexiAI provides the tools to generate, screen, and optimize names that are safe, compliant, and commercially viable.

Built by a team of regulatory experts, data scientists, and software engineers, LexiAI integrates multiple screening engines including phonetic similarity analysis, orthographic risk assessment, LASA (look-alike sound-alike) detection, trademark conflict screening, and multilingual validation. Our mission is to reduce medication errors and regulatory delays by ensuring every product name is thoroughly vetted before it reaches the market.